» Articles » PMID: 29925390

Characteristics and Survival Outcomes Related to the Infra-pyloric Lymph Node Status of Gastric Cancer Patients

Overview
Publisher Biomed Central
Date 2018 Jun 22
PMID 29925390
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: To study metastasis to the infra-pyloric (no. 6) lymph nodes and their subgroups and the related risk factors of gastric cancer patients.

Methods: Gastric cancer patients who underwent gastrectomy with complete postoperative pathological information on the no. 6 lymph node station and its subgroups from January 1, 2008, to December 31, 2011, were included. The clinicopathological characteristics and survival outcomes were analyzed.

Results: A total of 121 patients were included; they had 6.1 ± 7.7 positive lymph nodes, and 35.1 ± 14.2 lymph nodes were examined. The overall lymph node positivity rate was 67.8% (82/121) with a positivity rate of 28.1% (34/121) for the no. 6 lymph nodes. The metastasis rate was 6.6% for the no. 6a nodes, 6.6% for the no. 6b nodes, and 21.5% for the no. 6c nodes. Also, no. 8a (OR = 1.329, p = 0.017) and no. 9 (OR = 1.250, p = 0.022) nodal positivity and lower third tumor location (OR = 1.278, p = 0.001) were independent risk factors for no. 6 lymph nodal metastasis. There was a significant survival difference between patients with positive and negative no. 6 lymph nodes and patients with metastasis to other lymph node stations (p <  0.001).

Conclusions: Patients with no. 6 lymph node metastasis have poor survival outcomes. Complete infra-pyloric lymphadenectomy is necessary and crucial for gastric cancer patients.

Citing Articles

Role of Metabolomics in Pathogenesis and Prompt Diagnosis of Gastric Cancer Metastasis-A Systematic Review.

Ursu S, Ciocan A, Ursu C, Gherman C, Ciocan R, Pop R Diagnostics (Basel). 2023; 13(22).

PMID: 37998537 PMC: 10670422. DOI: 10.3390/diagnostics13223401.


Prognostic Score System Using Preoperative Inflammatory, Nutritional and Tumor Markers to Predict Prognosis for Gastric Cancer: A Two-Center Cohort Study.

Pang H, Zhang W, Liang X, Zhang Z, Chen X, Zhao L Adv Ther. 2021; 38(9):4917-4934.

PMID: 34379305 DOI: 10.1007/s12325-021-01870-z.


Laparoscopic infrapyloric lymph nodes dissection through the right bursa omentalis approach for gastric cancer.

Yang K, Zhang W, Liu K, Chen X, Chen X, Zhou Z BMC Surg. 2021; 21(1):216.

PMID: 33902530 PMC: 8077741. DOI: 10.1186/s12893-021-01192-5.


Discovering Biomarkers in Peritoneal Metastasis of Gastric Cancer by Metabolomics.

Pan G, Ma Y, Suo J, Li W, Zhang Y, Qin S Onco Targets Ther. 2020; 13:7199-7211.

PMID: 32801750 PMC: 7394602. DOI: 10.2147/OTT.S245663.


BATF2 reverses multidrug resistance of human gastric cancer cells by suppressing Wnt/β-catenin signaling.

Yang W, Wu B, Ma N, Wang Y, Guo J, Zhu J In Vitro Cell Dev Biol Anim. 2019; 55(6):445-452.

PMID: 31140101 DOI: 10.1007/s11626-019-00360-5.


References
1.
Blouhos K, Boulas K, Tsalis K, Hatzigeorgiadis A . Right-sided bursectomy as an access plane for aesthetic resection of the posterior leaf of the lesser sac from the head of the pancreas en block with the No. 6 and 14v lymph nodes in advanced lower third gastric cancer. Surgery. 2015; 158(6):1742. DOI: 10.1016/j.surg.2014.12.008. View

2.
. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011; 14(2):113-23. DOI: 10.1007/s10120-011-0042-4. View

3.
. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2016; 20(1):1-19. PMC: 5215069. DOI: 10.1007/s10120-016-0622-4. View

4.
Marutsuka T, Shimada S, Shiomori K, Hayashi N, Yagi Y, Yamane T . Mechanisms of peritoneal metastasis after operation for non-serosa-invasive gastric carcinoma: an ultrarapid detection system for intraperitoneal free cancer cells and a prophylactic strategy for peritoneal metastasis. Clin Cancer Res. 2003; 9(2):678-85. View

5.
Washington K . 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol. 2010; 17(12):3077-9. DOI: 10.1245/s10434-010-1362-z. View